Comparing two plasma p-tau217 assays for Alzheimer's detecti

Researchers compared two commercially available blood tests based on the biomarker p-tau217 for diagnosing Alzheimer's disease in 294 patients. Both tests demonstrated robust diagnostic capabilities, strongly correlating with established Alzheimer's biomarkers from PET scans.

Related Keywords

Lightspring Shutterstock , Janssen Simoa , Alzheimer Association , National Institute On , Two Plasmap Tau , Monitor Alzheimer , Image Credit , Translational Biomarkers , National Institute , Aging , Biomarker , Flood , Rain , Dementia , Iagnostic , Maging , Neurodegenerative Diseases , Pathology , Positron Emission Tomography , Omography ,